Date: Wednesday, August 26, 2020
OUR DISTINGUISHED PANELISTS
Jonas Grossman is Partner and President of chardan, where he oversees the firm's banking and capital markets activities. He has broad transactional experience having led or managed more than 400 transactions since joining Chardan in 2003. Under Mr. Grossman's leadership, Chardan has become one of the most notable underwriters, advisors and sponsors of SPACs, having underwritten 79 transactions raising $10.4billion with zero liquidations. Chardan has also served as advisor to 18 SPAC transactions.
Additionally, Mr. Grossman is President and Chief Executive Officer of Chardan's 6th sponsored SPAC, Chardan healthcare Acquisition 2 Corp, a healthcare focused SPAC. He was the Chief Executive Officer and President of chardan healthcare acquisition corp. from March 2018 until its merger in October 2019 with BiomX (NYSE: PHGE) where he remains on the board of directors. Mr. Grossman is currently a director of LifeSci Acquisition Corp. Additionally, Mr. Grossman has served as a founding partner for Cornix Advisors, LLC, a New York based hedge fund.
From 2001 until 2003, Mr. Grossman worked at Ramius Capital Group, LLC, a global multi-strategy hedge fund where he served as vice President and Head Trader. He holds a B.A. in Economics from Cornell University and an M.B.A. from NYU's Stern School of Business.
Co-CEO and CFO
Forum Merger II Corporation
Mr. Boris has over 30 years of Wall Street experience in mergers and corporate finance and has been involved in approximately 20 SPAC transactions as an advisor, investment banker and/or officer or board member, including ten business combinations totaling over $5.0 billion.
Mr. Boris is an active member of the Young Presidents' Organization, an organization with over 25,000 members who are in the top position of a qualifying company or division and are directly responsible for all operations of such business or division. Mr. Boris received a M.B.A. from Columbia University Business School and a B.A. from Vassar College, cum laude.
Jared Kelly's practice focuses on corporate finance transactions across the capital structure, including equity and debt securities offerings, traditional bank finance transactions, high yield bond issuances and convertible debt instruments. He also counsels companies in the energy, fintech, media and manufacturing industries regarding disclosure and corporate governance. Jared has broad experience ranging throughout the company lifecycle, and routinely manages large scale projects such as initial public offerings, leveraged acquisitions and corporate restructurings and recapitalizations.
Craig Lilly is a leading legal advisor for strategics and private equity clients on domestic and cross-border technology acquisitions, mergers, divestitures, recapitalizations, auctions, leveraged buyouts, and minority investments. Craig's practice includes advising emerging technology companies on venture capital financings, corporate governance, public offerings and joint ventures. He also represents fund sponsors in connection with structuring and organizing investment funds, parallel investment vehicles, and offshore funds. Craig frequently writes and lectures on legal and business issues regarding mergers and acquisitions, private equity investments and corporate finance. He has been quoted in, or contributed to, articles and features in Bloomberg, The wall street journal, Financier Worldwide, The Deal Magazine, Reuters, CFO.com and other major publications. He is a member of the Board of Directors of The Association for Corporate Growth – Silicon Valley.
Source: ACG New York